A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...
NEB's collaborative approach is built on close work with laboratory automation partners to automate, optimize and verify performance across a wide range of NEBNext products, including NEBNext ...
Twist Bioscience's Q1 growth was modest, due in large part to an air pocket in demand caused by a large NGS customer. Read ...
The use of next-generation sequencing (NGS) technologies to detect B-cell receptor (BCR) or T-cell receptor (TCR) clonotypes ...
NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are significant challenges. At Revvity, we are ...
Next-generation sequencing (NGS) has transformed the medical and biological sciences, providing improved throughput and affordability. The cost of whole-genome sequencing has reduced considerably, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results